In a recent cohort study of IBD patients, eNAMPT and eNAPRT levels were evaluated and found to be elevated in the blood and feces of IBD patients, and their levels correlated with pathological scores and high-sensitivity C-reactive protein (hsCRP) and confirmed the representation of predictive biomarkers for anti-TNF therapy response [200]. Here, CRP is linked to inflammatory bowel disease.